RALEXAR THERAPEUTICS, INC.

Profile

Company Names

RALEXAR THERAPEUTICS, INC.
ALEXAR THERAPEUTICS, INC.

Addresses

662 ENCINITAS BLVD., SUITE 250, ENCINITAS, CA 92024

640 LEE ROAD, SUITE 118, WAYNE, PA 19087

101 LINDENWOOD DRIVE, SUITE 400, MALVERN, PA 19355

Phone Numbers

484-318-2988

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2013

State Incorporated:

DELAWARE

Total Amount Raised:

$19,023,117.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2018-12-20 
$4,277,926.00 
$6,000,000.00 
$1,722,074.00 
Equity 
2
2017-05-31 
$4,145,191.00 
$6,908,638.00 
$2,763,447.00 
Equity 
1
2014-01-03 
$10,600,000.00 
$21,500,000.00 
$10,900,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
KAMIL 
 
ALI-JACKSON 
EXECUTIVE OFFICER
YAUPON THERAPEUTICS INC   |  CEPTARIS THERAPEUTICS, INC   |  ALEXAR THERAPEUTICS, INC.   |  ACLARIS THERAPEUTICS, INC.
DOUGLAS 
 
GESSL 
EXECUTIVE OFFICER
CEPTARIS THERAPEUTICS, INC   |  ALEXAR THERAPEUTICS, INC.   |  VELICEPT THERAPEUTICS, INC.   |  RALEXAR THERAPEUTICS, INC.   |  ONSPIRA THERAPEUTICS, INC.
JASON 
 
HONG 
DIRECTOR
AVEDRO INC   |  ALEXAR THERAPEUTICS, INC.   |  CATALYTIC IP INC   |  LYRIC PHARMACEUTICALS INC.   |  WOMBAT SECURITY TECHNOLOGIES, INC.   |  HEALTHTELL INC.   |  RALEXAR THERAPEUTICS, INC.   |  RUBRYC THERAPEUTICS, INC.
RAJU 
 
MOHAN 
EXECUTIVE OFFICER
ALEXAR THERAPEUTICS, INC.   |  OPPILAN PHARMA LTD   |  ESCALIER BIOSCIENCES B.V.   |  VENTYX BIOSCIENCES, INC.
DAVID 
 
PFEIFFER 
EXECUTIVE OFFICER, DIRECTOR
ELLMAN HOLDING CORP   |  ALEXAR THERAPEUTICS, INC.   |  CROSBY 2 LLC   |  RALEXAR THERAPEUTICS, INC.   |  NORDAQ ENERGY INC.
SOMASUNDARAM 
 
SUBRAMANIAM 
DIRECTOR
OBOPAY, INC.   |  DALI SYSTEMS CO. LTD.   |  ESCALIER BIOSCIENCES B.V.   |  CAMBRIDGE EPIGENETIX LTD   |  RALEXAR THERAPEUTICS, INC.   |  VENTYX BIOSCIENCES, INC.   |  NSV MASTER LIMITED PARTNERSHIP II, L.P.
SOMU 
 
SUBRAMANIAM 
DIRECTOR
BIOVEX GROUP, INC.   |  ACHRONIX SEMICONDUCTOR CORP   |  RF ARRAYS INC   |  LIGHTWIRE INC   |  RESOLVE THERAPEUTICS LLC   |  DALI SYSTEMS CO. LTD.   |  TRELLIS BIOSCIENCE LLC   |  BIOSCALE INC   |  SILICON SPACE TECHNOLOGY CORP   |  JUVENTAS THERAPEUTICS INC   |  DIRECTED SENSING INC.   |  PRIVATE GROUP NETWORKS, INC.   |  PERCEPTIMED, INC.   |  SVELTE MEDICAL SYSTEMS INC   |  ALEXAR THERAPEUTICS, INC.   |  NEW SCIENCE VENTURES FUND III, L.P.   |  NEW SCIENCE VENTURES FUND III (OFFSHORE), L.P.   |  VASCULAR THERAPIES INC   |  NSV 2016 OPPORTUNITIES FUND, L.P.   |  NSV 2016 OPPORTUNITIES FUND (OFFSHORE), L.P.   |  NSV 2017 OPPORTUNITIES FUND, L.P.   |  RALEXAR THERAPEUTICS, INC.   |  NSV 2018 NEW HORIZONS FUND, L.P.   |  NSV 2018 OPPORTUNITIES FUND, L.P.   |  NSV 2020 PREFERRED LP FUND, L.P.   |  NSV GROWTH OPPORTUNITIES FUND, L.P.   |  NSV 2021 GROWTH OPPORTUNITIES FUND, L.P.   |  PHASE FOUR, INC.   |  PAKAL TECHNOLOGIES, INC.   |  BRIGHTVOLT, INC   |  ABL SPACE SYSTEMS CO   |  GLYDWAYS, INC.   |  FERRIC, INC.
STEPHEN 
 
TULLMAN 
DIRECTOR, EXECUTIVE OFFICER
VICEPT THERAPEUTICS, INC.   |  YAUPON THERAPEUTICS INC   |  CEPTARIS THERAPEUTICS, INC   |  ACLARIS THERAPEUTICS, INC.   |  ALEXAR THERAPEUTICS, INC.   |  ZOOMI, INC.   |  VELICEPT THERAPEUTICS, INC.   |  RALEXAR THERAPEUTICS, INC.   |  ONSPIRA THERAPEUTICS, INC.   |  NEXEOS DIAGNOSTICS, INC.
NEAL 
 
WALKER 
DIRECTOR
VICEPT THERAPEUTICS, INC.   |  ACLARIS THERAPEUTICS, INC.   |  SEBACIA, INC.   |  ALEXAR THERAPEUTICS, INC.   |  ACTIVE PROTECTIVE TECHNOLOGIES, INC.   |  ALDEYRA THERAPEUTICS, INC.   |  ZOOMI, INC.   |  RALEXAR THERAPEUTICS, INC.   |  MYOTA, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-04-01
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-12-20 
2019-01-04
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-12-20 
2017-06-08
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-05-31 
2015-04-28
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-01-03 
2014-01-10
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-01-03 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#